Search published articles


Showing 2 results for Timp-1

Marzieh Khoshbin Nazdik, Zeinab Khazaei Koohpar, Arezo Sayad,
Volume 20, Issue 6 (9-2017)
Abstract

Abstract
Background: Matrix metalloproteinases (MMPs) comprise a family of proteolytic enzymes.MMPs are capable of disrupting the blood-brain barrier (BBB), mediating the destruction of extracellular matrix and myelin components. Tissue inhibitors of metalloproteinases (TIMPs) are proteins which block the activitiy of MMPs. Matrix metalloproteinase-9 (MMP-9) facilitates T-cell migration into the CNS while the tissue inhibitor matrix metalloproteinase-1 (TIMP-1) inhibits MMP-9 actions. The aim of this study was to evaluate the expression of TIMP-1 gene (in RNA level) in blood cells of relapsing-remitting multiple sclerosis (RRMS) patients treated with IFNb.
Materials and Methods: In this study, the expression level of TIMP-1 gene was investigated in blood cells of MS patients compared to healthy subjects by Real-Time PCR.
Results: The RRMS patients manifested a lower expression level of TIMP-1 RNA than their normal counterparts, although the result was not significant (p=0.1).
Conclusion: The results of this study showed that there was no linear correlation between TIMP-1 expression level and risk of Expanded Disability Status Scale of Kurtzke (EDSS); nor was there any significant correlation between expression status of TIMP-1 and duration of the disease. Further studies are recommended to compare TIMP-1 RNA in patients before and after taking IFN-beta.

Mahsa Kazemi Roodsari, Farhad Mashayekhi,
Volume 20, Issue 9 (12-2017)
Abstract

Abstract
Background: Matrix metalloproteinases (MMPs) are vital for the degradation/remodeling of the extra-cellular matrix, and are involved in spiral artery formation and invasion of endometrium during implantation. Tissue inhibitor of metalloproteinase 1 (TIMP1), is expressed in the several tissues of organisms and inhibits MMP activity. The aim of this investigation was to study the association between single-nucleotide polymorphism (SNP) in the TIMP1 (rs4898) (372 T/C) with in vitro fertilization and embryo transfer (IVF-ET) outcome by AS-PCR.
Materials and Methods: A total number of 200 blood samples including 100 IVF negative and 100 IVF positive (control) were collected in this study. DNA was extracted for TIMP1 genotyping. The genotype and allele frequencies of 372T/C polymorphism were examined by Allele-Specific PCR.
Results: The genotype frequencies of CC, CT and TT in 372 T/C polymorphism of TIMP1 gene in IVF- samples were 1%, 98% and 1%, respectively, while for IVF+ group were 7%, 91% and 2%, respectively (p=0.07). The allele frequencies of C and T in the IVF- were 50%, 50%, respectively and in IVF+ were 47.5%, 52.5%, respectively. The genotype and allele frequencies of TIMP1 rs4898 (372 T/C) did not differ between the patients and the control group (p=0.07 and p=0.68, respectively).
Conclusion: The results of this study indicate that SNP 372T/C of TIMP1 may not be associated with IVF-ET outcome in this population. Further studies with larger numbers of patients and controls are needed to confirm our results.    

 


Page 1 from 1     

© 2025 CC BY-NC 4.0 | Journal of Arak University of Medical Sciences

Designed & Developed by : Yektaweb